Sumitomo Mitsui Trust Holdings, Inc. Alkermes Plc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 13,000 shares of ALKS stock, worth $371,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,000
Previous 8,500
52.94%
Holding current value
$371,150
Previous $230,000
36.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$831 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$571 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$410 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$314 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$263 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.69B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...